“Atorvastatin for the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus: A Randomized Controlled Trial”

Background: Lithium remains the gold-standard treatment for bipolar disorder, with 30-40% of patients with responding preferentially to this medication 1-3. Additionally, lithium is commonly used in treatment-resistant… Read more ““Atorvastatin for the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus: A Randomized Controlled Trial””